ArticleCellular oncology (Dordrecht, Netherlands)2024

Nilotinib in combination with sunitinib renders MCL-1 for degradation and activates autophagy that overcomes sunitinib resistance in renal cell carcinoma.

Tingyu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.